It’s happened to all of us: you find the perfect model for your needs — a bracket, a box, a cable clip, but it only comes in ...
Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback